Albemarle (ALB) Projected to Post Earnings on Wednesday

Albemarle (NYSE:ALB) is projected to issue its Q4 2025 results after the market closes on Wednesday, February 11th. Analysts expect Albemarle to post earnings of ($0.62) per share and revenue of $1.3410 billion for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 12, 2026 at 8:00 AM ET.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.92) by $0.73. The business had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Albemarle had a positive return on equity of 0.10% and a negative net margin of 0.43%.Albemarle’s quarterly revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the business posted ($1.55) earnings per share. On average, analysts expect Albemarle to post $0 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Albemarle Stock Up 3.4%

Shares of ALB stock opened at $170.61 on Wednesday. Albemarle has a one year low of $49.43 and a one year high of $195.68. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.51. The stock has a fifty day moving average price of $151.93 and a 200 day moving average price of $110.73. The stock has a market cap of $20.08 billion, a P/E ratio of -107.30, a price-to-earnings-growth ratio of 2.95 and a beta of 1.44.

Hedge Funds Weigh In On Albemarle

Several institutional investors have recently bought and sold shares of the business. AQR Capital Management LLC grew its holdings in shares of Albemarle by 22,047.4% during the second quarter. AQR Capital Management LLC now owns 713,812 shares of the specialty chemicals company’s stock worth $44,613,000 after purchasing an additional 710,589 shares during the last quarter. Samlyn Capital LLC bought a new position in shares of Albemarle in the third quarter valued at about $47,088,000. Caisse de depot et placement du Quebec acquired a new position in Albemarle during the 3rd quarter worth about $41,239,000. Worldquant Millennium Advisors LLC lifted its position in Albemarle by 60.9% during the 2nd quarter. Worldquant Millennium Advisors LLC now owns 784,083 shares of the specialty chemicals company’s stock worth $49,138,000 after buying an additional 296,861 shares in the last quarter. Finally, Woodline Partners LP grew its holdings in Albemarle by 1,241.2% during the 3rd quarter. Woodline Partners LP now owns 170,476 shares of the specialty chemicals company’s stock worth $13,822,000 after acquiring an additional 157,765 shares during the last quarter. Institutional investors own 92.87% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on ALB shares. Rothschild & Co Redburn raised their price objective on shares of Albemarle from $135.00 to $158.00 and gave the stock a “buy” rating in a report on Thursday, December 4th. Weiss Ratings reissued a “sell (d+)” rating on shares of Albemarle in a research report on Monday, December 29th. Rothschild Redb upgraded shares of Albemarle to a “strong-buy” rating in a research note on Friday, October 24th. Berenberg Bank upped their price objective on Albemarle from $75.00 to $135.00 and gave the company a “hold” rating in a research note on Tuesday, January 6th. Finally, Oppenheimer increased their target price on Albemarle from $109.00 to $207.00 and gave the stock an “outperform” rating in a report on Wednesday, January 21st. Four equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Albemarle currently has an average rating of “Moderate Buy” and a consensus price target of $161.16.

Albemarle Company Profile

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.